Ledger. Australian venture funding, tracked

Company

The Yates Network

Coverage

Stories naming The Yates Network. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Funding announcement

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

Vaxxas reports positive Phase I results for its needle-free skin-patch delivery of a measles-rubella vaccine, with Gates Foundation grant funding and a planned PATH-sponsored Phase I/II trial in The Gambia.

Brandon BioCatalyst portfolio 26 Nov 2023 Bill & Melinda Gates FoundationBiomedical Advanced Research and Development AuthorityBrandon BioCatalystBrandon CapitalHealthcare VenturesOneVenturesOneVentures Innovation Fund IPATHThe University of QueenslandThe University of SydneyThe Yates NetworkUniQuestUniversity of OtagoUniversity of the Sunshine CoastVaxxasWE CommunicationAustralian GovernmentAmy MillerDr David L HoeyKathryn Morris
Funding announcement

Vaxxas Announces Interim Phase I Study Results for First Needle-Free HD-MAP COVID-19 Vaccine

Vaxxas reports encouraging interim Phase I results for its needle-free microarray-patch COVID-19 vaccine, with strong antibody responses and no serious adverse events, ahead of planned regulatory applications in Australia and the US.

Brandon Capital portfolio 6 Jun 2023 Bill & Melinda Gates FoundationBiomedical Advanced Research and Development AuthorityBrandon CapitalCEPIHealthcare VenturesOneVenturesOneVentures Innovation Fund IThe University of QueenslandThe University of Texas at AustinThe Yates NetworkUniQuestUniversity of the Sunshine CoastVaxxasWE CommunicationsWorld Health OrganizationAustralian GovernmentDr David L Hoey

Something wrong? Tell us